Higher cortisol tone suppresses hepatic SHBG production.

The relationship between cortisol, sex hormone-binding globulin (SHBG), and bioavailable sex steroids is complex, involving indirect metabolic pathways rather than direct transcriptional activation. Research indicates that while SHBG levels profoundly influence hormone bioavailability, cortisol's effect on SHBG is the opposite of what is often claimed.

Mechanistic explanations

Elevated cortisol tone does not increase hepatic SHBG production; instead, it typically suppresses it through metabolic intermediates:

• Insulin Resistance and Hyperinsulinemia: Cortisol promotes insulin resistance and compensatory hyperinsulinemia. Insulin is a potent inhibitor of hepatic SHBG production, as it reduces the binding of Hepatocyte Nuclear Factor 4-alpha (HNF4α) to the SHBG promoter, thereby decreasing gene transcription.
• Hepatic Steatosis (Fatty Liver): Cortisol facilitates the accumulation of triglycerides in the liver. Increased intrahepatic lipid content is strongly associated with down-regulated SHBG synthesis. Mechanistically, factors like SREBP-1c, which are elevated during lipid synthesis, further suppress SHBG expression.
• ER Stress: High glucocorticoid levels can induce endoplasmic reticulum (ER) stress in hepatocytes, which has been shown to impair the secretion of SHBG.

Clinical evidence

The claim that increased SHBG lowers bioavailable steroid signaling is well-supported by clinical data, particularly in the context of postmenopausal health:

• Free Hormone Hypothesis: In human physiology, only the "free" (unbound) fraction of testosterone and estradiol is considered biologically active. SHBG binds these hormones with high affinity, effectively sequestering them from their receptors.
• Postmenopausal Impact: For a 73-year-old female, SHBG levels are critical because total estrogen and androgen levels are already low. Even if total hormone levels remain stable, an increase in SHBG (driven by factors like oral estrogen therapy or thyroid hormone, but not cortisol) will significantly decrease the percentage of free, active hormone.
• Androgen/Estrogen Balance: SHBG has a higher affinity for testosterone than for estradiol. Therefore, increases in SHBG shift the balance toward a more estrogenic environment by disproportionately reducing bioavailable androgens.

Practical considerations

• Diagnostic Accuracy: Because total hormone levels may not reflect the actual hormonal status, measuring the Free Androgen Index (FAI) or calculating free testosterone/estradiol is often necessary in clinical assessments when SHBG levels are abnormal.
• Metabolic Context: In patients with high cortisol (e.g., Cushing’s syndrome or chronic stress), SHBG levels are typically low, not high. This low SHBG leads to an increase in free sex steroids, which can paradoxically contribute to symptoms like hirsutism in women despite relatively stable total androgen levels.

Bottom line

Higher cortisol tone suppresses rather than increases hepatic SHBG production by promoting insulin resistance and liver fat accumulation. However, if SHBG levels rise due to other factors, they will significantly lower bioavailable sex steroid signaling even if total hormone concentrations remain unchanged.